Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | HSCT for AML patients with FLT3-ITD: clinical practice recommendations

Ali Bazarbachi • 18 Aug 2020
EBMT 2020
Acute Myeloid Leukemia Leukemia Sorafenib

Ali Bazarbachi, MD, PhD, American University of Beirut Medical Center, Beirut, Lebanon, discusses clinical practice recommendations in hematopoietic stem cell transplant (HSCT) for acute myeloid leukemia (AML) patients with FLT3-internal tandem duplications (FLT3-ITD). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Explore the AML Channel banner with headshots of Naval Daver, Eunice Wang, and Thomas Cluzeau

More from Ali Bazarbachi

The role of allogeneic transplantation and immune therapies following CAR-T failure in DLBCL
9:18
The role of allogeneic transplantation and immune therapies following CAR-T failure in DLBCL
Ali Bazarbachi • 31 Mar 2026
A large retrospective analysis evaluating changes in transplant outcomes over time in relapsed HL
10:40
A large retrospective analysis evaluating changes in transplant outcomes over time in relapsed HL
Ali Bazarbachi • 24 Jun 2025
The role of NGS profiling in patients with AML undergoing alloSCT
5:36
The role of NGS profiling in patients with AML undergoing alloSCT
Ali Bazarbachi • 10 Apr 2025
The evolution of SCT in Hodgkin lymphoma with the introduction of BV and checkpoint inhibitors
2:38
The evolution of SCT in Hodgkin lymphoma with the introduction of BV and checkpoint inhibitors
Ali Bazarbachi • 10 Apr 2025

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals